Stereotaxis Stock Beta

STXS Stock

USD 2.23 0.06 2.62%

Stereotaxis fundamentals help investors to digest information that contributes to Stereotaxis' financial success or failures. It also enables traders to predict the movement of Stereotaxis Stock. The fundamental analysis module provides a way to measure Stereotaxis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Stereotaxis stock.

Non Currrent Assets Other Non Current Assets Total

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Stereotaxis Company Beta Analysis

Stereotaxis' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

Covariance

Variance

More About Beta | All Equity Analysis

Current Stereotaxis Beta

1.55

Most of Stereotaxis' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stereotaxis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Stereotaxis Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for Stereotaxis is extremely important. It helps to project a fair market value of Stereotaxis Stock properly, considering its historical fundamentals such as Beta. Since Stereotaxis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Stereotaxis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Stereotaxis' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Current Deferred Revenue	Net Debt	Accounts Payable	Long Term Debt	Net Receivables	Total Current Assets	Treasury Stock	Short Term Debt	Common Stock	Property Plant Equipment	Short Term Investments	Intangible Assets	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Good Will	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.75	-0.23	-0.18	0.0	-0.43	0.44	-0.24	0.03	0.96	-0.15	-0.08	0.74	0.63	0.32	-0.03	0.73	-0.32	0.48	-0.28	-0.06	0.13	-0.31	0.79	0.79	-0.36
Total Stockholder Equity	0.75		-0.03	-0.77	-0.55	-0.84	-0.14	-0.65	-0.56	0.82	0.23	-0.54	0.68	0.33	0.34	-0.29	0.82	-0.54	0.59	-0.24	-0.28	0.15	-0.54	0.88	0.88	-0.4
Retained Earnings	-0.23	-0.03		-0.2	-0.55	0.0	-0.14	0.13	-0.22	-0.05	0.89	0.17	-0.55	-0.2	0.09	0.13	-0.53	0.55	-0.69	-0.11	0.64	-0.31	0.57	-0.47	-0.47	0.41
Total Liab	-0.18	-0.77	-0.2		0.82	0.83	0.63	0.73	0.88	-0.3	-0.49	0.72	-0.33	0.1	-0.2	0.4	-0.5	0.49	-0.44	0.11	0.35	-0.11	0.5	-0.54	-0.54	0.13
Current Deferred Revenue	0.0	-0.55	-0.55	0.82		0.66	0.57	0.45	0.79	-0.18	-0.74	0.47	-0.03	0.22	-0.04	0.44	-0.16	0.11	-0.04	0.06	0.11	0.03	0.11	-0.21	-0.21	0.01
Net Debt	-0.43	-0.84	0.0	0.83	0.66		0.42	0.81	0.77	-0.55	-0.29	0.68	-0.46	-0.09	0.03	0.4	-0.67	0.65	-0.53	0.26	0.42	-0.15	0.66	-0.71	-0.72	0.34
Accounts Payable	0.44	-0.14	-0.14	0.63	0.57	0.42		0.35	0.69	0.3	-0.3	0.54	0.24	0.68	0.09	0.19	-0.01	0.2	-0.11	-0.25	0.33	0.1	0.22	-0.01	-0.01	-0.07
Long Term Debt	-0.24	-0.65	0.13	0.73	0.45	0.81	0.35		0.71	-0.28	-0.18	0.58	-0.49	-0.1	-0.19	0.34	-0.61	0.89	-0.55	0.38	0.39	-0.26	0.88	-0.63	-0.64	0.39
Net Receivables	0.03	-0.56	-0.22	0.88	0.79	0.77	0.69	0.71		-0.1	-0.55	0.75	-0.12	0.18	-0.14	0.58	-0.32	0.44	-0.4	0.0	0.47	-0.17	0.45	-0.32	-0.31	0.12
Total Current Assets	0.96	0.82	-0.05	-0.3	-0.18	-0.55	0.3	-0.28	-0.1		0.04	-0.12	0.65	0.49	0.28	-0.06	0.69	-0.27	0.38	-0.3	0.0	0.05	-0.25	0.77	0.76	-0.33
Treasury Stock	-0.15	0.23	0.89	-0.49	-0.74	-0.29	-0.3	-0.18	-0.55	0.04		-0.19	-0.38	-0.14	0.16	-0.08	-0.22	0.28	-0.35	-0.07	0.37	0.01	0.3	-0.21	-0.21	0.09
Short Term Debt	-0.08	-0.54	0.17	0.72	0.47	0.68	0.54	0.58	0.75	-0.12	-0.19		-0.17	0.0	-0.15	0.39	-0.51	0.49	-0.62	0.04	0.65	-0.26	0.51	-0.46	-0.46	0.34
Common Stock	0.74	0.68	-0.55	-0.33	-0.03	-0.46	0.24	-0.49	-0.12	0.65	-0.38	-0.17		0.44	0.2	-0.35	0.84	-0.67	0.77	-0.18	-0.44	0.34	-0.67	0.87	0.87	-0.36
Property Plant Equipment	0.63	0.33	-0.2	0.1	0.22	-0.09	0.68	-0.1	0.18	0.49	-0.14	0.0	0.44		0.21	0.02	0.36	-0.17	0.31	-0.12	0.02	0.19	-0.17	0.4	0.4	-0.25
Short Term Investments	0.32	0.34	0.09	-0.2	-0.04	0.03	0.09	-0.19	-0.14	0.28	0.16	-0.15	0.2	0.21		-0.04	0.18	-0.1	0.13	-0.12	0.04	-0.14	-0.1	0.23	0.22	-0.06
Intangible Assets	-0.03	-0.29	0.13	0.4	0.44	0.4	0.19	0.34	0.58	-0.06	-0.08	0.39	-0.35	0.02	-0.04		-0.27	0.3	-0.38	-0.19	0.75	-0.1	0.33	-0.24	-0.24	0.15
Net Tangible Assets	0.73	0.82	-0.53	-0.5	-0.16	-0.67	-0.01	-0.61	-0.32	0.69	-0.22	-0.51	0.84	0.36	0.18	-0.27		-0.73	0.85	-0.14	-0.5	0.48	-0.73	0.97	0.97	-0.69
Long Term Debt Total	-0.32	-0.54	0.55	0.49	0.11	0.65	0.2	0.89	0.44	-0.27	0.28	0.49	-0.67	-0.17	-0.1	0.3	-0.73		-0.73	0.33	0.56	-0.31	1.0	-0.73	-0.73	0.46
Capital Surpluse	0.48	0.59	-0.69	-0.44	-0.04	-0.53	-0.11	-0.55	-0.4	0.38	-0.35	-0.62	0.77	0.31	0.13	-0.38	0.85	-0.73		0.01	-0.73	0.6	-0.75	0.79	0.79	-0.48
Deferred Long Term Liab	-0.28	-0.24	-0.11	0.11	0.06	0.26	-0.25	0.38	0.0	-0.3	-0.07	0.04	-0.18	-0.12	-0.12	-0.19	-0.14	0.33	0.01		-0.23	0.04	0.3	-0.18	-0.18	-0.04
Long Term Investments	-0.06	-0.28	0.64	0.35	0.11	0.42	0.33	0.39	0.47	0.0	0.37	0.65	-0.44	0.02	0.04	0.75	-0.5	0.56	-0.73	-0.23		-0.22	0.6	-0.44	-0.44	0.31
Good Will	0.13	0.15	-0.31	-0.11	0.03	-0.15	0.1	-0.26	-0.17	0.05	0.01	-0.26	0.34	0.19	-0.14	-0.1	0.48	-0.31	0.6	0.04	-0.22		-0.31	0.3	0.3	-0.56
Short Long Term Debt	-0.31	-0.54	0.57	0.5	0.11	0.66	0.22	0.88	0.45	-0.25	0.3	0.51	-0.67	-0.17	-0.1	0.33	-0.73	1.0	-0.75	0.3	0.6	-0.31		-0.73	-0.73	0.46
Net Invested Capital	0.79	0.88	-0.47	-0.54	-0.21	-0.71	-0.01	-0.63	-0.32	0.77	-0.21	-0.46	0.87	0.4	0.23	-0.24	0.97	-0.73	0.79	-0.18	-0.44	0.3	-0.73		1.0	-0.59
Net Working Capital	0.79	0.88	-0.47	-0.54	-0.21	-0.72	-0.01	-0.64	-0.31	0.76	-0.21	-0.46	0.87	0.4	0.22	-0.24	0.97	-0.73	0.79	-0.18	-0.44	0.3	-0.73	1.0		-0.59
Capital Stock	-0.36	-0.4	0.41	0.13	0.01	0.34	-0.07	0.39	0.12	-0.33	0.09	0.34	-0.36	-0.25	-0.06	0.15	-0.69	0.46	-0.48	-0.04	0.31	-0.56	0.46	-0.59	-0.59

Click cells to compare fundamentals

In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.

Competition

Predict Stereotaxis

In accordance with the recently published financial statements, Stereotaxis has a Beta of 1.551. This is 80.35% higher than that of the Health Care Equipment & Supplies sector and 76.25% higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.

Stereotaxis Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stereotaxis' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Stereotaxis could also be used in its relative valuation, which is a method of valuing Stereotaxis by comparing valuation metrics of similar companies.

Stereotaxis is currently under evaluation in beta category among its peers.

Stereotaxis Current Valuation Drivers

We derive many important indicators used in calculating different scores of Stereotaxis from analyzing Stereotaxis' financial statements. These drivers represent accounts that assess Stereotaxis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Stereotaxis' important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	333.5M	370.3M	468.5M	157.4M	141.2M	111.3M
Enterprise Value	307.7M	330.8M	435.8M	154.7M	126.9M	110.4M

Stereotaxis ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Stereotaxis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Stereotaxis' managers, analysts, and investors.

Environmental

Governance

Social

As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Stereotaxis will likely underperform.

Stereotaxis Fundamentals

	Return On Equity	-1.06
	Return On Asset	-0.29
	Profit Margin	(0.86) %
	Operating Margin	(0.69) %
	Current Valuation	189.83 M
	Shares Outstanding	84.73 M
	Shares Owned By Insiders	15.63 %
	Shares Owned By Institutions	48.50 %
	Number Of Shares Shorted	3.07 M
	Price To Earning	21.61 X
	Price To Book	17.47 X
	Price To Sales	7.51 X
	Revenue	26.77 M
	Gross Profit	18.47 M
	EBITDA	(21.24 M)
	Net Income	(20.71 M)
	Cash And Equivalents	30.94 M
	Cash Per Share	0.41 X
	Total Debt	5.49 M
	Debt To Equity	0.18 %
	Current Ratio	2.96 X
	Book Value Per Share	0.13 X
	Cash Flow From Operations	(9.14 M)
	Short Ratio	11.30 X
	Earnings Per Share	(0.27) X
	Target Price	4.5
	Number Of Employees	122
	Beta	1.55
	Market Capitalization	188.95 M
	Total Asset	41.91 M
	Retained Earnings	(537.68 M)
	Working Capital	20.02 M
	Current Asset	17.14 M
	Current Liabilities	16.14 M
	Net Asset	41.91 M

About Stereotaxis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Stereotaxis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stereotaxis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stereotaxis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Stereotaxis Stock Analysis

When running Stereotaxis' price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC